DINGDANG HEALTH TECHNOLOGY GROUP LTD. 叮噹健康科技集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：09886） (1)執 行 董 事 及 副 總 裁 辭 任；及(2)委任執行董事及副總裁 董 事 會 謹 此 宣 佈，自2026年2月16日 起： 叮 噹 健 康 科 技 集 團 有 限 公 司（「本公司」，連 同 其 附 屬 公 司 及 綜 合 聯 屬 實 體 統 稱「本集團」）董 事（「董 事」）會（「董事會」）謹 此 宣 佈 董 事 會 的 以 下 變 動。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部份內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 孟先生於2013年7月 於 中 國 北 京 獲 得 北 京 航 天 航 空 大 學 經 濟 學（項 目 管 理） 專業網絡教育專科 畢業證書。 孟 先 生 已 與 本 公 司 訂 立 服 務 合 約，初 步 任 期 自2026年2 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 FF301 公司名稱: 叮噹健康科技集團有限公司(於開曼群島註冊成立的有限公司) 呈交日期: 2026年2月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 09886 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | USD | | 0.0001 USD | | 500,000 | | 增加 / 減少 (-) | | | 0 | | | USD | | | | 本月底結存 | | | 5,000,000,000 | USD | | 0.0001 USD | | 500,000 | 本月底法 ...

Group 1 - Ant Group's Aifoo has upgraded its PC platform and launched the DeepSearch feature, providing professional services for medical professionals, including doctors and medical students [1] - Aifoo has surpassed 10 million user inquiries per day, leveraging its self-developed Ant Medical Health model, and over 1,000 doctors have created their AI avatars on the Aifoo app to provide 24/7 health consultation [1] - Aifoo is collaborating with Dingdang Health on "smart pharmacy + instant fulfillment" to ensure efficient service delivery when users are directed to Dingdang's smart pharmacy [1] Group 2 - Dingdang Health operates a nationwide "28-minute home delivery" smart pharmacy network, supports medical insurance payments, and offers 24-hour online pharmacist services [3] - Dingdang Health effectively bridges the gap in "medical AI service implementation," transforming AI health management from "advice" to "solutions," creating a complete user experience loop of "AI guidance + instant professional service" [3]

Group 1 - The core point of the article is that Dingdang Health has been actively repurchasing its shares, with a total of 2,398.85 million shares repurchased since November 25, 2025, amounting to 2,666.24 million HKD [2] - On January 16, 2026, the company repurchased 5.2145 million shares at a price range of 1.050 to 1.240 HKD, with a total repurchase amount of 584.22 million HKD [2] - The stock price closed at 1.090 HKD on the same day, reflecting a decline of 11.38%, with a total trading volume of 17.4298 million HKD [2] Group 2 - Year-to-date, the company has conducted 11 repurchase transactions, totaling 1,473.20 million shares and a total repurchase amount of 1,672.21 million HKD [2] - The stock has experienced a cumulative increase of 5.83% during the repurchase period [2] - A detailed breakdown of the repurchase activities shows varying amounts and prices, with the highest repurchase price recorded at 1.240 HKD on January 16, 2026 [2]

Group 1 - The core point of the article is that Dingdang Health has been actively repurchasing its shares, with a total of 5.21 million shares bought back on January 16 at prices ranging from 1.050 to 1.240 HKD, amounting to 5.84 million HKD [1] - Since November 25, 2025, the company has conducted share repurchases for 36 consecutive days, totaling 23.99 million shares and a cumulative repurchase amount of 26.66 million HKD [1] - The stock has seen a cumulative increase of 5.83% during the repurchase period [1] Group 2 - In 2026, the company has completed 11 repurchase transactions, acquiring a total of 14.73 million shares for a total amount of 16.72 million HKD [1] - The detailed repurchase data shows varying prices and amounts, with the highest repurchase price recorded at 1.240 HKD and the lowest at 1.050 HKD on January 16 [1] - The stock closed at 1.090 HKD on the same day, reflecting an 11.38% decline with a total trading volume of 17.43 million HKD [1]

Core Viewpoint - Dingdang Health (09886) announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Group 1: Buyback Details - The company will repurchase 5.2145 million shares at a total cost of HKD 5.8422 million [1] - The buyback price per share ranges from HKD 1.05 to HKD 1.24 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 叮噹健康科技集團有限公司 呈交日期： 2026年1月16日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 09886 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | | 佔 ...

Group 1 - The company Dingdong Health (09886) announced a share buyback plan, intending to repurchase approximately 2.866 million shares at a cost of about HKD 3.4805 million [1] - The share buyback is scheduled for January 15, 2026, indicating the company's strategy to enhance shareholder value [1] - This move reflects the company's confidence in its financial position and future prospects [1]

Group 1 - The company Dingdang Health (09886.HK) announced a share buyback on January 15, spending HKD 3.481 million to repurchase 2.866 million shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 叮噹健康科技集團有限公司 FF305 | 1). | 已購回以作註銷但尚未註銷之股份 | | 410,000 | 0.031073 % | HKD | 1.051 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年11月25日 | | | | | | 2). | 已購回以作註銷但尚未註銷之股份 | | 170,000 | 0.012884 % | HKD | 1.0533 | | | 變動日期 | 2025年11月26日 | | | | | | 3). | 已購回以作註銷但尚未註銷之股份 | | 69,000 | 0.005229 % | HKD | 1.0787 | | | 變動日期 | 2025年11月27日 | | | | | | 4). | 已購回以作註銷但尚未註銷之股份 | | 251,000 | 0.019023 % | HKD | 1.0888 | | | 變動日期 | ...